Jiangsu Hengrui Medicine
600276.SS
#501
Rank
NZ$88.16 B
Marketcap
NZ$13.28
Share price
-1.77%
Change (1 day)
11.93%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Quarterly Reports

Thumbnail Jiangsu Hengrui Medicine
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: Chinese

View Quarterly Report